DexCom, Inc. DXCM

86.62 (0.85) (0.97%) as of 25 Sep
Market cap
$33.0B
P/E
33.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

DexCom, Inc. (DXCM) P/E ratio

As of 25 September 2026, DexCom, Inc. (DXCM) trades at a P/E ratio of 33.4×. Over the past ten years it has ranged from 0.0× (December 2019) to 311× (November 2018); the current reading is higher than 46% of that period. That is above the Medical Devices industry median of 22.2× and above the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 30.9× (41.65%)
FY2024 52.9× (39.40%)
FY2023 87.3× (33.04%)
FY2022 130× (53.62%)
FY2021 281× 292.28%
FY2020 71.7× (64.30%)
FY2019 201× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly

Period P/E ratio Change
Jun 2026 26.0× (0.62%)
Mar 2026 26.2× (15.24%)
Dec 2025 30.9× (15.13%)
Sep 2025 36.4× (39.16%)
42 more quarters

Against its own ten years

Low 0.0× High 311×
Ten-year median 40.1×
Current reading's percentile 46

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on DXCM